Toshiyuki Fukao
Papers
1
Total Citations
36
H-Index
1
About
Dr. Toshiyuki Fukao is a leading figure in the field of inborn errors of metabolism, with a particular focus on the diagnosis and monitoring of lysosomal storage disorders. His most impactful work centers on the development of innovative biochemical assays for mucopolysaccharidoses (MPS), a group of rare genetic diseases. Dr. Fukao’s major contribution is the creation of a novel, automated high-throughput mass spectrometry method for quantifying heparan sulfate, a key biomarker for MPS. This breakthrough, detailed in his highly cited 2014 paper (36 citations), has revolutionized screening and monitoring protocols, enabling faster, more accurate, and less invasive diagnosis. His work has significantly improved the clinical management of MPS patients, allowing for earlier intervention and better tracking of disease progression and treatment efficacy. Dr. Fukao’s research exemplifies the translation of cutting-edge analytical chemistry into tangible clinical benefits, making him a pivotal figure in metabolic medicine and a key resource for researchers and clinicians working to improve outcomes for patients with these devastating disorders.
Research Focus
Key Achievements
Top Papers
- 1